Pfizer Inc
RFK Jr.’s vaccine panel weakens Covid shot recommendations, calling it an individual decision
Members of the Advisory Committee on Immunization Practices (ACIP) listen to a presentation about COVID-19 (coronavirus disease) during an Advisory Committee on Immunization Practices (ACIP) meeting at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, U.S., Sept. 19, 2025. Alyssa Pointer | Reuters Health and Human Services Secretary Robert F. Kennedy Jr.’s […]
Read More
Stocks making the biggest premarket moves: Intel, Novo Nordisk, Bullish, Cracker Barrel and more
Check out the companies making the biggest moves in premarket trading: Intel — The semiconductor maker soared 30% after Nvidia said it will invest $5 billion in Intel to co-develop data center and PC products. Nvidia added 3%, one day after it lost 2.6%. Novo Nordisk — The Danish drugmaker jumped 7.6% after late-stage results […]
Read More
Covid shot access, coverage at stake as RFK Jr.’s hand-picked vaccine panel convenes
Ruth Jones, immunization nurse, holds a Pfizer-BioNTech COVID-19 vaccine (brand name: Comirnaty) at Borinquen Health Care Center in Miami, Florida, on May 29, 2025. Joe Raedle | Getty Images Covid shot access and coverage in the U.S. hang in the balance as an influential government vaccine panel hand-picked by Health and Human Services Secretary Robert […]
Read More
Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021. Dado Ruvic | Reuters Shares of Pfizer and Moderna fell on Friday after a report that Trump administration health officials plan to link Covid vaccines to the deaths of 25 children. The report from the […]
Read More
RFK Jr. casts doubts on vaccines, clashes with Democrats over Covid shot access
U.S. Health and Human Services Secretary Robert F. Kennedy Jr., testifies before a Senate Finance Committee hearing on President Donald Trump’s 2026 health care agenda, on Capitol Hill in Washington, D.C., U.S., September 4, 2025. Jonathan Ernst | Reuters Health and Human Services Secretary Robert F. Kennedy Jr. doubled down on false claims about vaccines […]
Read More
Trump tells drugmakers to ‘justify the success’ of Covid meds after FDA limits vaccine approval
U.S. President Donald Trump in the Cabinet Room of the White House on Aug. 26, 2025 in Washington, D.C. Chip Somodevilla | Getty Images President Donald Trump on Monday called on pharmaceutical companies to “justify the success” of their Covid drugs days after the Food and Drug Administration set new limits on who can receive […]
Read More
The vaccine and public health debate at the center of CDC upheaval, explained
The exterior of the Center for Disease Control and Prevention (CDC) main campus in Atlanta, Georgia, U.S., Aug. 27, 2025. Alyssa Pointer | Reuters The Centers for Disease Control and Prevention is facing a leadership upheaval — and at the center of the shakeup is concern about the agency’s approach to vaccines and U.S. public […]
Read More
FDA approves new Covid shots with limits on who can get them, as RFK Jr. changes vaccine precedents
Pfizer’s Covid vaccine Comirnaty, seen at a CVS Pharmacy in Eagle Rock, California, Sept. 14, 2023. Irfan Khan | Los Angeles Times | Getty Images The Food and Drug Administration on Wednesday approved the latest round of Covid vaccines in the U.S., but set new limits on who can get them. The agency ended its […]
Read More
A world on weight loss drugs: How GLP-1s are reshaping the economy
Eternalcreative | Istock | Getty Images Miracle drugs, obesity treatments and skinny jabs. Call them what you will, few drugs have had a more transformative effect on Wall Street and waistlines over recent decades than GLP-1s. Familiarly known under the brand names Wegovy and Zepbound, Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medication used to […]
Read More
Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly‘s stock is still recovering after the drugmaker released trial data earlier this month on its closely watched obesity pill that underwhelmed Wall Street. In a key late-stage trial, […]
Read More